Vident Advisory, LLC Dexcom Inc Transaction History
Vident Advisory, LLC
- $5.7 Trillion
- Q4 2024
A detailed history of Vident Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 5,217 shares of DXCM stock, worth $464,678. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,217
Previous 30,541
82.92%
Holding current value
$464,678
Previous $2.05 Billion
80.18%
% of portfolio
0.01%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding DXCM
# of Institutions
1,072Shares Held
339MCall Options Held
6.74MPut Options Held
6.33M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.14 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.07 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.49 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.3 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.28 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...